5350 NE Dawson Creek Drive
97124 Hillsboro, Oregon, us
+1 (0) 949 428 3872
FEI launches Top-of-the-Line Research Dualbeam at M&M
Helios NanoLab™ DualBeam Will Enable Industry-Leading Nanoscale Imaging, Analysis, Fabrication and Sample Prep Applications
The Helios NanoLab features a new ultra-high resolution field emission SEM column combined with FEI’s widely acclaimed Sidewinder™ FIB column and gas chemistries to provide new levels of imaging resolution and contrast in a DualBeam system. It also delivers enhanced stability and optimized operation within a wide range of parameters. The new small DualBeam platform enables industry-leading 3D characterization, analysis and image reconstruction applications, nano-prototyping (fabrication and testing) capabilities, and high-quality sample prep abilities for researchers and developers needing to reach deep into the nanoscale.
“The Helios NanoLab was designed to address the demanding requirements of our growing base of DualBeam users in both research and product development environments,” said Rob Fastenau, senior vice president of FEI’s NanoResearch and Industry market division. “FEI continues to lead innovation in combined FIB/SEM solutions. We believe that users of this all-new DualBeam platform will be able to achieve ground-breaking results in multiple applications with accuracy and repeatability.”
With its advanced sample preparation capabilities, the Helios NanoLab complements FEI’s Titan S/TEM—the world’s most powerful microscope—which continues to receive industry acclaim since its launch at last year’s Microscopy & Microanalysis show. The Helios system enables fast and precise preparation of the thinnest S/TEM samples with little damage to samples. Together, the Helios NanoLab and the Titan S/TEM represent the highest-performance tool set currently available on the commercial market.
FEI introduced the world’s first combined FIB/SEM system in 1993. Since 2000, it has sold more than 350 small stage DualBeam systems worldwide.
This news release contains forward-looking statements that include statements about performance of a newly-introduced product and future product performance. Factors that could affect these forward-looking statements include, but are not limited to changes to or cancellation of product application development initiatives; problems arising during product rollout that delay it or cause results to vary from the anticipated results; unforeseen technology challenges; and failure of a key supplier or partner. Please also refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statements.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.